Cargando…
Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. NAFLD stages range from simple steatosis (NAFL) to non-alcoholic steatohepatitis (NASH) which can progress to cirrhosis and hepatocellular carcinoma. One of the crucial events clearly involved in N...
Autores principales: | Rada, Patricia, González-Rodríguez, Águeda, García-Monzón, Carmelo, Valverde, Ángela M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519685/ https://www.ncbi.nlm.nih.gov/pubmed/32978374 http://dx.doi.org/10.1038/s41419-020-03003-w |
Ejemplares similares
-
Insights Into Extracellular Vesicles as Biomarker of NAFLD Pathogenesis
por: Garcia-Martinez, Irma, et al.
Publicado: (2020) -
GCKIII kinases in lipotoxicity: Roles in NAFLD and beyond
por: Mahlapuu, Margit, et al.
Publicado: (2022) -
Editorial: New Insights Into Understanding and Managing NAFLD
por: Escribano, Óscar, et al.
Publicado: (2021) -
Intrahepatic Expression of Fatty Acid Translocase CD36 Is Increased in Obstructive Sleep Apnea
por: Rey, Esther, et al.
Publicado: (2020) -
Hypoxia‐inducible factor 2α drives hepatosteatosis through the fatty acid translocase CD36
por: Rey, Esther, et al.
Publicado: (2020)